The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis

Schoonheim, MM; Ciccarelli, O; (2018) The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis. [Editorial comment]. Neurology , 90 (15) pp. 677-678. 10.1212/WNL.0000000000005279. Green open access

Preview

Text
Ciccarelli_677.full.pdf - Published Version
Download (128kB) | Preview

Type:	Article
Title:	The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1212/WNL.0000000000005279
Publisher version:	https://doi.org/10.1212/WNL.0000000000005279
Language:	English
Additional information:	This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords:	Multiple sclerosis
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation
URI:	https://discovery.ucl.ac.uk/id/eprint/10040857

Downloads since deposit

0Downloads

Download activity - last month

Download activity - last 12 months

Downloads by country - last 12 months

Archive Staff Only

View Item